Clinical emergence of a novel extended-spectrum variant deriving from the OXY-1 β-lactamase
European Journal of Clinical Microbiology & Infectious Diseases · 2024
DOI: 10.1007/s10096-024-04922-8 ↗Kurz gefasst
Fallbericht in der Zeitschrift European Journal of Clinical Microbiology & Infectious Diseases, 2024. Verfasst von Anne-Sophie Hong Tuan Ha und 6 weiteren Autor:innen. Beteiligte Einrichtung: Service de Bactériologie, Assistance Publique Hôpitaux de Paris, Hôpitaux Universitaires Paris Centre, Site Cochin, 27 rue du Faubourg Saint-Jacques,…. Hauptthemen laut MEDLINE: beta-Lactamases, Ceftazidime, Drug Resistance, Multiple, Bacterial, Klebsiella. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben.
Abstract (Originalsprache)
The genomic comparison of two Klebsiella michiganensis clinical isolates recovered from the same patient, one resistant to piperacillin-tazobactam and intermediate to cefotaxime, the other resistant to ceftazidime but susceptible to piperacillin-tazobactam, revealed one mutation in the blaOXY-1-24 gene accounting for a L169M substitution in the Ω loop. Cloning experiment in Escherichia coli demonstrated the contribution of this mutation to the hydrolysis spectrum extension towards ceftazidime and cefepime, whereas the resistance to piperacillin-tazobactam was reduced. To the best of our knowledge, this study shows for the first time that ceftazidime resistance can occur in vivo from OXY-1 precursor by structural alteration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Service de Bactériologie, Assistance Publique Hôpitaux de Paris, Hôpitaux Universitaires Paris Centre, Site Cochin, 27 rue du Faubourg Saint-Jacques, Paris, 75014, France.
- INSERM, CNRS, Institut Necker Enfants Malades, Université Paris Cité, , Paris, 75015, France.
- Institut Cochin, INSERM U1016, CNRS UMR8104, Université de Paris Cité, Paris, France.
- Service de Bactériologie, Assistance Publique Hôpitaux de Paris, Hôpitaux Universitaires Paris Centre, Site Cochin, 27 rue du Faubourg Saint-Jacques, Paris, 75014, France. hedi.mammeri@aphp.fr.
- INSERM, CNRS, Institut Necker Enfants Malades, Université Paris Cité, , Paris, 75015, France. hedi.mammeri@aphp.fr.
Zitieren
APA
Hong Tuan Ha, A. S., Mammeri, A., Plainvert, C., Charfi, R., Poyart, C., Tazi, A., & Mammeri, H. (2024). Clinical emergence of a novel extended-spectrum variant deriving from the OXY-1 β-lactamase. European Journal of Clinical Microbiology & Infectious Diseases. https://doi.org/10.1007/s10096-024-04922-8
Vancouver
Hong Tuan Ha AS, Mammeri A, Plainvert C, Charfi R, Poyart C, Tazi A, et al. Clinical emergence of a novel extended-spectrum variant deriving from the OXY-1 β-lactamase. European Journal of Clinical Microbiology & Infectious Diseases. 2024. doi:10.1007/s10096-024-04922-8
BibTeX
@article{HongTuanHa2024,
author = {Hong Tuan Ha, Anne-Sophie and Mammeri, Alice and Plainvert, Céline and Charfi, Rym and Poyart, Claire and Tazi, Asmaa and Mammeri, Hedi},
title = {Clinical emergence of a novel extended-spectrum variant deriving from the OXY-1 β-lactamase},
journal = {European Journal of Clinical Microbiology & Infectious Diseases},
year = {2024},
doi = {10.1007/s10096-024-04922-8}
}
EUVIMED